BACKGROUND: Rapidly undertaken age-stratified serology studies can produce valuable data about a new emerging infection including background population immunity and seroincidence during an influenza pandemic. Traditionally seroepidemiology studies have used surplus laboratory sera with little or no clinical information or have been expensive detailed population based studies. We propose collecting population based sera from the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), a sentinel network with extensive clinical data. AIM:To pilot a mechanism to undertake population based surveys that collect serological specimens and associated patient data to measure seropositivity and seroincidence due to season...
INTRODUCTION: Rapid Point of Care Testing (POCT) for influenza could be used to provide information ...
International audienceINTRODUCTION: The COVID-19 pandemic caused by SARS-CoV-2 threatens global publ...
International audienceBACKGROUND: Knowledge of the age-specific prevalence of seroprotection and inc...
BACKGROUND: Rapidly undertaken age-stratified serology studies can produce valuable data about a new...
BACKGROUND: Rapidly undertaken age-stratified serology studies can produce valuable data about a new...
Background: After the introduction of any new pandemic influenza, population-level surveillance and ...
Background Serological studies can detect infection with a novel influenza virus in the absence of s...
BACKGROUND: Point-of-care testing (POCT) for influenza promises to provide real-time information to ...
Background: Point-of-care testing (POCT) for influenza promises to provide real-time information to ...
Background: Assessing severity and spread of a novel influenza strain at the start of a pandemic is ...
OBJECTIVES: The objectives of the H1N1 2009 serological surveillance project were twofold: to docume...
Background: Point-of-care testing (POCT) for influenza promises to provide real-time information to ...
Serological studies can detect infection with a novel influenza virus in the absence of symptoms or ...
After the introduction of any new pandemic influenza, population-level surveillance and rapid assess...
AIM:To pilot enhanced safety surveillance of seasonal influenza vaccine meeting the European Medicin...
INTRODUCTION: Rapid Point of Care Testing (POCT) for influenza could be used to provide information ...
International audienceINTRODUCTION: The COVID-19 pandemic caused by SARS-CoV-2 threatens global publ...
International audienceBACKGROUND: Knowledge of the age-specific prevalence of seroprotection and inc...
BACKGROUND: Rapidly undertaken age-stratified serology studies can produce valuable data about a new...
BACKGROUND: Rapidly undertaken age-stratified serology studies can produce valuable data about a new...
Background: After the introduction of any new pandemic influenza, population-level surveillance and ...
Background Serological studies can detect infection with a novel influenza virus in the absence of s...
BACKGROUND: Point-of-care testing (POCT) for influenza promises to provide real-time information to ...
Background: Point-of-care testing (POCT) for influenza promises to provide real-time information to ...
Background: Assessing severity and spread of a novel influenza strain at the start of a pandemic is ...
OBJECTIVES: The objectives of the H1N1 2009 serological surveillance project were twofold: to docume...
Background: Point-of-care testing (POCT) for influenza promises to provide real-time information to ...
Serological studies can detect infection with a novel influenza virus in the absence of symptoms or ...
After the introduction of any new pandemic influenza, population-level surveillance and rapid assess...
AIM:To pilot enhanced safety surveillance of seasonal influenza vaccine meeting the European Medicin...
INTRODUCTION: Rapid Point of Care Testing (POCT) for influenza could be used to provide information ...
International audienceINTRODUCTION: The COVID-19 pandemic caused by SARS-CoV-2 threatens global publ...
International audienceBACKGROUND: Knowledge of the age-specific prevalence of seroprotection and inc...